Jay A. Fishman, M.D. is Professor of Medicine at Harvard Medical School (HMS), Director of the Transplant Infectious Diseases and Compromised Host Program at Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center. Dr. Fishman received his MD from Johns Hopkins University School of Medicine, internal medicine training and Infectious Disease Fellowship at MGH, and Fellowships in Molecular Biology and Genetics at MGH and HMS. Dr. Fishman established the Transplant and Immunocompromised Host Program of the MGH, the first worldwide. He defined use of ganciclovir for CMV infection in transplantation, molecular biology of Pneumocystis and porcine endogenous retrovirus and performed the first studies of porcine cytomegalovirus (PCMV) in primate models of xenotransplantation. He is Fellow of the American College of Physicians, American Society of Transplantation, and Infectious Disease Society of America. He is Past-President of the American Society of Transplantation, President-elect of the International Xenotransplantation Association, and Councilor of the Transplantation Society. He has received career achievement awards from AST and TTS.
When | Session | Talk Title | Room |
---|---|---|---|
Tue-30 11:00 - 12:30 |
Plenary Session — Advanced technologies in clinical xenotransplantation: Genetics and multi-omics | Moderator | Auditorium |
Fri-03 08:30 - 10:00 |
Plenary Session — Infectious diseases: Have we made xeno safe enough to proceed? | Overview: Microbiological Safety in XenoTx – pigs and patients | Auditorium |
Committee | Role | Section |
---|---|---|
International Advisory Board | Member | |
IXA Council | President-Elect | |
IXA 2025 Congress Board | Member |